TYRX HistoryTYRX is comprised of highly experienced polymer chemists, pharmaceutical scientists, materials engineers, and visionary business leaders. January 16, 2008AIGISRx™ gains FDA 510 k clearance for use with implantable pacemakers and implantable defibrillators. May 14, 2008Dr. Ali Massumi, Director of the Center for Cardiac Arrhythmias and Electrophysiology at St. Luke’s Hospital and Clinical Professor of Medicine at Houston’s Baylor College of Medicine, implants the first AIGISRx™. Dr. Massumi inserted a replacement dual chamber pacemaker into the AIGISRx™ Anti-Bacterial surgical mesh envelope in less than a minute. September 26, 2008TYRX launches the AIGISRx™ ICD designed to accommodate an implantable cardioverter defibrillator. The launch of AIGISRx™ ICD extends TYRX’s AIGISRx™ CRMD (cardiac rhythm management device) platform to the ICD market.
|